The latest price target for Nanobiotix (NASDAQ:NBTX) was reported by Guggenheim on February 6, 2026. The analyst firm set a price target for $26.00 expecting NBTX to fall to within 12 months (a possible -36.12% downside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Nanobiotix (NASDAQ:NBTX) was provided by Guggenheim, and Nanobiotix maintained their buy rating.

There is no last upgrade for Nanobiotix

There is no last downgrade for Nanobiotix.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nanobiotix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nanobiotix was filed on February 6, 2026 so you should expect the next rating to be made available sometime around February 6, 2027.

While ratings are subjective and will change, the latest Nanobiotix (NBTX) rating was a maintained with a price target of $8.00 to $26.00. The current price Nanobiotix (NBTX) is trading at is $40.70, which is out of the analyst’s predicted range.